Chemically Modifying IL-2 to Optimize Delivery to Tregs for Sustained Responses
Time: 4:00 pm
day: Day One | Track B | Afternoon
Details:
- Overview of PEGylated IL2v to enhance activation of Tregs with high specificity and maintain stability
- Highlighting preclinical data to predict clinical efficacy of PEGylated IL2v
- Overcoming the challenges to translate from preclinical models to humans
